Effectiveness of 4% Articaine as local anaesthetic agent in pediatric dentistry

Comparative Evaluation Of Onset Of Action And Efficacy Of 2% Lignocaine And 4% Articaine After Administration Of Local Anaesthesia For Pulp Therapy Of Primary Maxillary Molars In Children Aged 5-10 Years : A Randomized Clinical Trial. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064277

Enrollment

Registered

2024-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: 2% Lignocaine: Local anaesthetic agent. Dosage: 1 ml (maximum permissible dose of 7 mg/kg) given as injection intraorally once before treatment Intervention2: 4% Articaine: Local anaest

Eligibility

Inclusion criteria

Inclusion criteria: Patients with maxillary molars requiring pulpectomy treatment

Exclusion criteria

Exclusion criteria: Medically compromised patients

Design outcomes

Primary

Measure	Time frame
Onset of action of Articaine 4% and Lignocaine 2%(recorded in seconds)Timepoint: Time will be recorded only once after administration of local anaesthesia	—

Secondary

Measure	Time frame
Efficacy of Articaine 4% & Lignocaine 2%Timepoint: Measured after access opening of the tooth anaesthetized (once)	—

Countries

India

Contacts

Public ContactDr Sanika Karmarkar

Department of Pediatric and Preventive Dentistry, KLE VK Institute of dental sciences, Belgaum

badakar@gmail.com9902773259

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026